Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

Moderna is seeking emergency use authorization from the FDA for its Covid-19 vaccine for children 6 months through 5 years of age.

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

While an emergency use authorization may be the speediest way for public health officials to begin a vaccination campaign, it may not end up shaving that much time off of a more traditional route to ...

Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and ...

What is an emergency use authorization? An emergency use authorization is a tool that the FDA uses to strengthen the nation’s response to public health emergencies such as COVID-19.

The FDA issued an emergency use authorization to drug-maker Lilly for bamlanivimab, a monoclonal antibody that mimics the immune system’s response to infection with the virus that causes COVID-19.

The first COVID-19 vaccine was distributed under an Emergency Use Authorization. More than seven months later, actual approval hasn’t been granted.

Emergency use authorization can be granted when a vaccine meets certain standards during a time when there is extreme risk to public health.

Emergency use authorization can be granted when a vaccine meets certain standards during a time when there is extreme risk to public health.